RxDoctor Payments Data

Drew Winston

Infectious Disease · Los Angeles, CANPI 1265655203

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $2,160 of the $2,188 with a category attached, or 98.7%. Janssen Global Services, LLC accounts for 98.7% of it on its own, with 1 other manufacturer making up the rest.

$2,188in general payments, 2019–2025

Across 2 payments — averaging $1093.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Janssen Global Services, LLC$2K
  • Sobi, Inc$28
$694,329in research payments, 2019–2025

Across 57 payments — averaging $12,181 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Takeda Pharmaceuticals U.S.A., Inc.$352K
  • Shire North American Group Inc$175K
  • Cidara Therapeutics, Inc.$98K
  • Janssen Research & Development, LLC$37K
  • Gilead$13K
  • Reviral, Inc.$13K
  • plus $7K from 1 others

What the payments were for

  • Consulting fees$2,16099%
  • Food & beverage$281%

General payments by program year

19
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Janssen Global Services, LLC1$2,160
Sobi, Inc1$28

How this compares

$2,188 in reported general payments places this provider in the 75th percentile of 856 infectious disease providers in California.

See all infectious disease providers in California

Other infectious disease in Los Angeles

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →